| 000 | 01735 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514024906.0 | ||
| 264 | 0 | _c20020522 | |
| 008 | 200205s 0 0 eng d | ||
| 022 | _a0901-9928 | ||
| 024 | 7 |
_a10.1034/j.1600-0773.2001.d01-154.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHalladay, A K | |
| 245 | 0 | 0 |
_aRole of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release. _h[electronic resource] |
| 260 |
_bPharmacology & toxicology _cNov 2001 |
||
| 300 |
_a237-48 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a3,4-Dihydroxyphenylacetic Acid _xmetabolism |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aClorgyline _xpharmacology |
| 650 | 0 | 4 |
_aCorpus Striatum _xdrug effects |
| 650 | 0 | 4 |
_aDopamine _xmetabolism |
| 650 | 0 | 4 | _aDrug Interactions |
| 650 | 0 | 4 |
_aFenclonine _xpharmacology |
| 650 | 0 | 4 |
_aFenfluramine _xtoxicity |
| 650 | 0 | 4 |
_aHomovanillic Acid _xmetabolism |
| 650 | 0 | 4 |
_aHydroxyindoleacetic Acid _xmetabolism |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMonoamine Oxidase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSelegiline _xpharmacology |
| 650 | 0 | 4 |
_aSerotonin _xmetabolism |
| 650 | 0 | 4 |
_aSerotonin Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aSelective Serotonin Reuptake Inhibitors _xtoxicity |
| 650 | 0 | 4 |
_aTryptophan _xpharmacology |
| 650 | 0 | 4 |
_aalpha-Methyltyrosine _xpharmacology |
| 700 | 1 | _aKirschner, E | |
| 700 | 1 | _aHesse, K | |
| 700 | 1 | _aFisher, H | |
| 700 | 1 | _aWagner, G C | |
| 773 | 0 |
_tPharmacology & toxicology _gvol. 89 _gno. 5 _gp. 237-48 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1034/j.1600-0773.2001.d01-154.x _zAvailable from publisher's website |
| 999 |
_c11788815 _d11788815 |
||